SFX by Ex Libris Inc.

Title:	Systematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarction
Source:	European Journal of Human Genetics [1018-4813] Brænne, Ingrid yr:2015

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Full text available via PubMed Central

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Mulders, Ties A. "Asymptomatic individuals with a positive family history for premature coronary artery disease and elevated coronary calcium scores benefit from statin treatment: a post hoc analysis from the st. Francis heart study." JACC. Cardiovascular imaging 5.3 (2012): 252-260.
description	2.	Hart, Padraig J. "Molecular diagnosis of familial hypercholesterolaemia." Current opinion in lipidology 28.4 (2017): 1-320.
description	3.	Day, Ian N M N. "FH4=STAP1. Another Gene for Familial Hypercholesterolemia? Relevance to Cascade Testing and Drug Development?" Circulation research 115.6 (2014): 534-536.
description	4.	Albert, Michelle A. "Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial." The American heart journal 162.1 (2011): 106-14.
description	5.	Olsson, Anders G. "LDL cholesterol goals and cardiovascular risk during statin treatment: the IDEAL study." European journal of cardiovascular prevention and rehabilitation 18.2 (2011): 262-269.
description	6.	Conceicao, I. "Definition of a putative pathological region in PARK2 associated with autism spectrum disorder through in silico analysis of its functional structure." Psychiatric genetics 27.2 (2017): 54-61.
description	7.	Ntaios, G. "Serum cholesterol levels and sepsis." Atherosclerosis. Supplement 8.1 (2007): 34-34.
description	8.	Hovingh, K. "Mutations in STAP1 are Associated With Autosomal Dominant Hypercholesterolemia." Circulation research 115.6 (2014): 552-5.
description	9.	Falk, E. "The High-Risk Plaque Initiative: Primary Prevention of Atherothrombotic Events in the Asymptomatic Population." Current atherosclerosis reports 13.5 (2011): 359-366.
description	10.	Johansen, Christopher T. "Genetic bases of hypertriglyceridemic phenotypes." Current opinion in lipidology 22.4 (2011): 247-253.
description	11.	Erbel, R. "Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study." Journal of the American College of Cardiology 56.17 (2010): 1397-1406.
description	12.	McPherson, R. "Canadian Cardiovascular Society position statement -- Recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease." The Canadian journal of cardiology 22.11 (2006): 913-927.
description	13.	Bell, R. "The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines." The Canadian journal of cardiology 27 Suppl A.3 (2011): 1-59.
description	14.	McKelvie, Robert S. "The 2012 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Acute and Chronic Heart Failure." The Canadian journal of cardiology 29.2 (2012): 168-181.
description	15.	Dasgupta, K. "The 2014 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and TreatmentÂ of Hypertension." The Canadian journal of cardiology 30.5 (2014): 485-501.
description	16.	Sharp, A. "Ethnicity and Left Ventricular Diastolic Function in Hypertension An ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) Substudy." Journal of the American College of Cardiology 52.12 (2008): 1015-21.
description	17.	Genest, J. "2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations." The Canadian journal of cardiology 25.10 (2009): 567-579.
description	18.	Xie, H G G. "Molecular basis of ethnic differences in drug disposition and response." Annual review of pharmacology and toxicology 41.1 (2001): 815-50.
description	19.	Nies, Leslie K K. "Complementary and alternative therapies for the management of dyslipidemia." The Annals of pharmacotherapy 40.11 (2006): 1984-92.
description	20.	Aqua, K. "Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: A randomized, double-blind, active- and placebo-controlled, parallel-group trial." Clinical therapeutics 29.6 (2007): 1000-1012.